These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29358208)

  • 1. New hope for unsanctioned safe injection site.
    Glauser W
    CMAJ; 2018 Jan; 190(3):E90-E91. PubMed ID: 29358208
    [No Abstract]   [Full Text] [Related]  

  • 2. 'It's our safe sanctuary': Experiences of using an unsanctioned overdose prevention site in Toronto, Ontario.
    Foreman-Mackey A; Bayoumi AM; Miskovic M; Kolla G; Strike C
    Int J Drug Policy; 2019 Nov; 73():135-140. PubMed ID: 31654936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Another Senseless Death - The Case for Supervised Injection Facilities.
    Wakeman SE
    N Engl J Med; 2017 Mar; 376(11):1011-1013. PubMed ID: 28296603
    [No Abstract]   [Full Text] [Related]  

  • 4. Supervised injection facilities in Canada: past, present, and future.
    Kerr T; Mitra S; Kennedy MC; McNeil R
    Harm Reduct J; 2017 May; 14(1):28. PubMed ID: 28521829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary health care for people who inject drugs in low and middle income countries.
    Myers BJ
    Int J Drug Policy; 2012 Mar; 23(2):105-6. PubMed ID: 22030256
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of an Unsanctioned Safe Consumption Site in the United States.
    Kral AH; Lambdin BH; Wenger LD; Davidson PJ
    N Engl J Med; 2020 Aug; 383(6):589-590. PubMed ID: 32640126
    [No Abstract]   [Full Text] [Related]  

  • 7. Mitigating the heroin crisis in Baltimore, MD, USA: a cost-benefit analysis of a hypothetical supervised injection facility.
    Irwin A; Jozaghi E; Weir BW; Allen ST; Lindsay A; Sherman SG
    Harm Reduct J; 2017 May; 14(1):29. PubMed ID: 28532488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of combination approach on harm reduction programs: the Taiwan experience.
    Lin T; Chen CH; Chou P
    Harm Reduct J; 2016 Jul; 13(1):23. PubMed ID: 27377896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syringe exchange in community pharmacies--The Portuguese experience.
    Torre C; Lucas R; Barros H
    Int J Drug Policy; 2010 Nov; 21(6):514-7. PubMed ID: 20956074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ODYSSEAS: supervised use of drugs versus bureaucracy in Greece.
    Malliori M; Galinaki S; Papakonstantinou AK
    Lancet Psychiatry; 2015 Feb; 2(2):e3. PubMed ID: 26359756
    [No Abstract]   [Full Text] [Related]  

  • 11. Expanding supervised injection facilities across Canada: lessons from the Vancouver experience.
    Young S; Fairbairn N
    Can J Public Health; 2018 Apr; 109(2):227-230. PubMed ID: 29981039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ireland is to install supervised injecting rooms.
    Houston M
    BMJ; 2016 Jan; 532():i406. PubMed ID: 26801053
    [No Abstract]   [Full Text] [Related]  

  • 13. Science versus politics: the need for supervised injection facilities in Montreal, Canada.
    Jozaghi E
    Int J Drug Policy; 2012 Sep; 23(5):420-1. PubMed ID: 22818890
    [No Abstract]   [Full Text] [Related]  

  • 14. [Services for drug users. Making a difference in many lives].
    Medellín JM
    Sidahora; 2005; ():12-7. PubMed ID: 16634157
    [No Abstract]   [Full Text] [Related]  

  • 15. The cost-effectiveness of harm reduction.
    Wilson DP; Donald B; Shattock AJ; Wilson D; Fraser-Hurt N
    Int J Drug Policy; 2015 Feb; 26 Suppl 1():S5-11. PubMed ID: 25727260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Controlled drug consumption rooms].
    Allilaire JF; Costentin J; Goullé JP; Hamon M; Laqueille X; Lejoyeux M; Mouren MC; Olié JP; Nordmann R; Tillement JP
    Bull Acad Natl Med; 2013 Feb; 197(2):503-5. PubMed ID: 24919375
    [No Abstract]   [Full Text] [Related]  

  • 17. Commentary on Vickerman et al. (2012): Reducing hepatitis C virus among injection drug users through harm reduction programs.
    Smith-Spangler CM; Asch SM
    Addiction; 2012 Nov; 107(11):1996-7. PubMed ID: 23039752
    [No Abstract]   [Full Text] [Related]  

  • 18. COVID-19 and Rural Harm Reduction Challenges in the US Southern Mountains.
    Ostrach B; Buer LM; Armbruster S; Brown H; Yochym G; Zaller N
    J Rural Health; 2021 Jan; 37(1):252-255. PubMed ID: 32652621
    [No Abstract]   [Full Text] [Related]  

  • 19. The projected costs and benefits of a supervised injection facility in Seattle, WA, USA.
    Hood JE; Behrends CN; Irwin A; Schackman BR; Chan D; Hartfield K; Hess J; Banta-Green C; Whiteside L; Finegood B; Duchin J
    Int J Drug Policy; 2019 May; 67():9-18. PubMed ID: 30802842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV and drugs: a common, common-sense agenda for 2016.
    Buse K; Albers E; Phurailatpam S
    Lancet Glob Health; 2016 May; 4(5):e292-3. PubMed ID: 27080461
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.